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URETHANE, which induces lung tumours in mice and rats (Nettleship and
Henshaw, 1943; Jaffe, 1947; Cowen, 1947), also causes a notable decrease of
malignant and normal leucocytes (Paterson, Haddow, ApThomas and Watkin-
son, 1946; Cowen, 1947). The present study was undertaken to investigate
any correlation between the carcinogenic and leucopaenic properties of urethane.
The mixture of pentose nucleotides as prepared from yeast nucleic acids is
used clinically in the treatment of agranulocytosis, and it has been found to
elicit leucocytosis in mice (Parsons, 1945). Since pentose nucleotides have the
opposite effect of urethane with respect to their action on leucocytes, the possi-
bility that the carcinogenic effect of urethane might be antagonized by pentose
nucleotides was considered.
MATERIALS AND METHODS.
The mixture of pentose nucleotides used was the commercial preparation, as
supplied by Menley & James Ltd. in 10 c.c. sterile vials, each containing 0-7 g.
of a mixture of the sodium salts of the four nucleotides of yeast ribonucleic acid
preserved with 0-3 per cent cresol.
The mice used were the F1 cross of the A and C 57 lines. These were chosen
because A mice have a relatively high spontaneous lung tumour incidence
(Bittner, 1939; Heston, 1940), and it has been observed that such strains respond
more readily to the carcinogenic effect of urethane (Cowen, 1947). The hybrids
would also tend to have a high spontaneous incidence, since the inheritance of
spontaneous lung tumours in this cross seems to be due to a single dominant
gene (Bittner and Little, 1937; Bittner, 1938).
Seventeen A x C 57 males approximately two months old were injected with
the pentose nucleotides solution subcutaneously at the flanks, daily at mid-
morning. The dosage was 0-1 c.c. for 3 days, 0-2 c.c. for 4 days, 0-4 c.c. for 1
day,and then a 0-1 per cent solution ofurethane was substituted for the drinking
water. After continuing to inject 0-4 c.c. of pentose nucleotides for a week the
mice started to show ill effects. Both treatments were discontinued (after 2
weeks of pentose nucleotides and 1 week of urethane treatment) for two days,
to rest the mice. On resuming treatments the dosage of pentose nucleotides
was decreased to 0-3 c.c. daily. This rate of dosage was tolerated much better.
Eight weeks from the time of the first injection the urethane solution was re-
placed by tap water, and four days later the injections ofthe pentose nucleotides
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As controls, 9 A x C 57 hybrid males, also 2 months old, were treated
similarly with urethane only (Control 1). In order to ensure that the urethane
was being administered well above threshold level, a further group of 11 identical
control mice (Control 2) were similarly treated but for a period of 3 months,
i.e. 5 weeks longer than Control 1 and the experimental mice.
All the animals were kept for 7 months from the beginning of treatment, and
then sacrificed.
RESULTS.
Thirteen of the 17 mice treated with both pentose nucleotides and urethane,
8 of the 9 Control 1 mice and 9 of the 11 Control 2 mice survived the experiment.
After separating the lobes, the total number of lung tumours in each mouse
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FIG. 1.-Frequency polygon showing number of lung tumours in AxC 57 mice treated with
urethane and pentose nucleotides compared with AxC 57s treated with urethane only.
was counted with the naked eye and was plotted as a frequency polygon (Fig. 1).
The shaded areas represent Control 1 mice. The figure clearly shows that a
marked inhibition ofthe carcinogenicity ofurethane was producedby thepentose
nucleotides.
The average number of lung tumours per mouse caused by urethane in
Controls 1 and 2 separately was 46 in each case, which was reduced to 26 in the
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group receiving pentose nucleotides. This represents a decrease of 43 per cent
in tumour incidence.
The highest number of lung tumours found in the pentose nucleotides treated
mice, 42, was exceeded by 13 of the 17 controls which received urethane alone.
As already noted, the average number oflung tumours per mouse in Control 1
was the same as inControl 2. This indicates that the urethane was mostprobably
exerting its maximum carcinogenic activity during treatment with the pentose
nucleotides. It is to be suspected that with a lower dosage of urethane, the
pentose nucleotides treatment might have been even more efficient in inhibiting
lung tumours.
DISCUSSION.
The results of this experiment show that there seems to be some connection,
direct or indirect, between the carcinogenicity of urethane and its leucopaenic
properties, since the carcinogenic effect is inhibited by a substance which causes
leucocytosis.
The exact mode of action of urethane, as a carcinogen specific for lung,
remains obscure. Various possibilities exist; one is that urethane, resembling
so many normal tissue components, substitutes for one or more of them and
upsets metabolism. Haddow and Sexton (1946), in their work on the inhibition
of the Walker rat tumnour by urethane, suggest an upset of purine metabolism.
This would fit in with the present results, since pentose nucleotides, here shownto
antagonize the action of urethane, contains purine and pyrimidine compounds.
If lung tumours were not directly the effect of a purine metabolism upset,
then a second possible path of action presents itself. The deviation of purine
metabolism may be responsible for the leukopaenia noted (Paterson et al., 1946;
Cowen, 1947), which in turn lowers the resistance of the animals to some latent
organism in the lung which would be responsible for the tumnours (Nettleship and
Henshaw, 1943). This involves a direct connection between the carcinogenicity
of urethane and its leucopaenic powers. It is interesting to note that narcotics
and certain other substances chemically related to urethane are neither carcino-
genic for lung nor have they been noted for leucopaenic properties (Larsen,
Rhoads and Weed, 1946; Cowen, 1947). The pentose nucleotides might
therefore act by directly supplementing the normal cell purines, rendering the
urethane ineffective as far as metabolism deviation is concerned; or it may
independently of this purine mechanism produce leucocytosis, thus neutralizing
the leucopaenic action of urethane. In both cases antagonism of the carcino-
genicity of urethane by pentose nucleotides is explained whether it acted by a
straight metabolic upset or through a virus or similar organism.
Further important information could be obtained if each of the four nucleo-
tides, in the mixture used, were separately tested for anti-carcinogenic effects,
noting if the same ones were responsible for leucocytosis, since this property
varies between them (Parsons, Gulland and Barker, 1947). At the present
time the pure nucleotides are not available in the quantities required for work
of this nature. The "purine deviation " hypothesis above would suggest that
the purine or pyrimidine bases alone might be anti-carcinogenic.
It has also been suggested that urethane acts as a carcinogen by merely
speeding up a natural process (Cowen, 1947). This was concluded, since theINDUCTION OF MUTATIONS BY CARCINOGEN 97
incidence of urethane induced lung tumours bears a relationship to the incidence
of spontaneous lung tumours in various inbred lines of mice. In this event,
pentose nucleotides would be expected to have an inhibitory action on the
formation of spontaneous lung tumours.
SUMMARY.
1. Pentose nucleotides, when injected into mice receiving treatment with
urethane, decreases almost by half the number of lung tumours caused by it.
2. Possible modes of action of urethane as a carcinogen for lung were dis-
cussed, especially with respect to its leucopaenic action.
All expenses in connection with this work were borne by the British Empire
Cancer Campaign.
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THE idea of somatic mutation as an explanation for the origin of cancer has
had a long and interesting history. Its original use as an interpretation ofcancer
is usually associated with the names of Murray and of Boveri. These men
arrived at the somatic mutation conclusion from different fields, Murray from
experimental cancer research, and Boveri from his classical observations in
experimental embryology. A -good description of the origin of cancer was
formulated by Murray (1908). At that time he stated: "The existence of such
tumours, the biological characters of which are retained through long periods of
propagation, shows that the cellular transformation which initiates carcinomatous
growth may take place in varying degrees. The impress which the cells receive,
at this time, while permitting ofgreat histological variations in their descendants,
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